Cognizant Technology Solutions Corp. (Nasdaq: CTSH) has agreed to acquire MarketRx Inc., a Bridgewater, N.J.-based provider of analytics and related software to life sciences companies. The deal is valued at approximately $135 million in cash, and is expected to close later this year. MarketRx has raised over 48 million in VC funding, from firms like WestBridge Capital Partners.
Cognizant Technology Solutions Corporation (NASDAQ: CTSH), a leading provider of global IT and business process outsourcing services, today announced that it has signed a definitive agreement to acquire NJ-based marketRx, Inc., a leading provider of analytics and related software services to global Life Sciences companies in the pharmaceutical, biotechnology and medical devices segments. Cognizant will pay approximately $135 million in cash, which will be funded from current cash reserves.
This acquisition strengthens Cognizant's full-suite of offerings across all areas of the Life Sciences value chain